in pursuit of this goal , we examined the ability of foxhounds with surgically implanted hepatic arterial ( ha ) delivery systems to tolerate a clinically relevant dosage of ha yttrium-90 ( y-90 ) by microsphere administration either alone or preceded by a 28-day constant ha infusion of either 5-bromo-2'-deoxyuridine ( budr ) or a control solution .
C0011535
deoxyuridine
C0006233
budr